Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory
Reuters
Aug 04
Zhong Ji Longevity Science Group Ltd. Enters MOU for Potential Acquisition of Asian Integrated Cell Laboratory
Zhong Ji Longevity Science Group Limited has announced that it has entered into a non-legally binding memorandum of understanding with China International Osteoarticular Medical Group Limited. The agreement outlines a potential acquisition where Zhong Ji Longevity Science Group intends to purchase 100% of the shareholding interest in Asian Integrated Cell Laboratory Limited. This acquisition aligns with the company's strategic focus on advancing cell therapies and cell drugs in areas such as cancer prevention, anti-aging, and knee health. Mr. Yan Li, the Chairman and executive Director of Zhong Ji Longevity Science Group, is also the sole director and sole shareholder of the Vendor, making the transaction a connected transaction. The company plans to keep shareholders and investors updated with further announcements as developments occur.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhong Ji Longevity Science Group Ltd. published the original content used to generate this news brief on August 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.